The endothelial lipase protein is promising urinary biomarker for diagnosis of gastric cancer

Diagnostic Pathology

Volumn 8, Issue 1, 2013, Pages

  Dong, Xueyan ^a   Wang, Guoqing ^a   Zhang, Guoqing ^b   Ni, Zhaohui ^a   Suo, Jian ^c   Cui, Juan ^d   Cui, Ai ^a   Yang, Qing ^a   Xu, Ying ^d,e   Li, Fan ^a  

^a Basic Medical College   (China)

^b XINJIANG MEDICAL UNIVERSITY   (China)

^c THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^d University of Georgia   (United States)

^e JILIN UNIVERSITY   (China)

Author keywords

Biomarker; Diagnosis; Endothelial lipase; Gastric cancer

Indexed keywords

LIPG PROTEIN, HUMAN; TRIACYLGLYCEROL LIPASE; TUMOR MARKER;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD; CANCER GRADING; CANCER STAGING; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; ENZYMOLOGY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PATHOLOGY; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; STOMACH TUMOR; URINE; VERY ELDERLY; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; AREA UNDER CURVE; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LIPASE; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; ROC CURVE; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

MLCS; MLOWN;

EID: 84875041393     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-8-45     Document Type: Article

References (34)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61:69-90. 10.3322/caac.20107, 21296855.
2. Bertuccio P, Chatenoud L, Levi F, Praud D, Ferlay J, Negri E, Malvezzi M, La Vecchia C. Recent patterns in gastric cancer: a global overview. Int J Cancer 2009, 125:666-673. 10.1002/ijc.24290, 19382179.
3. Wu K, Nie Y, Guo C, Chen Y, Ding J, Fan D. Molecular basis of therapeutic approaches to gastric cancer. J Gastroenterol Hepatol 2009, 24:37-41. 10.1111/j.1440-1746.2008.05753.x, 19196394.
4. Jin J, Jin T, Quan M, Piao Y, Lin Z. Ezrin overexpression predicts the poor prognosis of gastric adenocarcinoma. Diagn Pathol 2012, 7:135. 10.1186/1746-1596-7-135, 3502371, 23039327.
5. Ren J, Chen Z, Juan SJ, Yong XY, Pan BR, Fan DM. Detection of circulating gastric carcinoma-associated antigen MG7-Ag in human sera using an established single determinant immuno-polymerase chain reaction technique. Cancer 2000, 88:280-285. 10.1002/(SICI)1097-0142(20000115)88:2<280::AID-CNCR6>3.0.CO;2-7, 10640958.
6. Xu Y, Zhang L, Hu G. Potential application of alternatively glycosylated serum MUC1 and MUC5AC in gastric cancer diagnosis. Biologicals 2009, 37:18-25. 10.1016/j.biologicals.2008.08.002, 18848467.
7. Kon OL, Yip TT, Ho MF, Chan WH, Wong WK, Tan SY, Ng WH, Kam SY, Eng A, Ho P. The distinctive gastric fluid proteome in gastric cancer reveals a multi-biomarker diagnostic profile. BMC Med Genomics 2008, 1:54. 10.1186/1755-8794-1-54, 2584050, 18950519.
8. Adachi J, Kumar C, Zhang Y, Olsen JV, Mann M. The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins. Genome Biol 2006, 7:R80. 10.1186/gb-2006-7-9-r80, 1794545, 16948836.
9. Feldman AS, Banyard J, Wu CL, McDougal WS, Zetter BR. Cystatin B as a tissue and urinary biomarker of bladder cancer recurrence and disease progression. Clin Cancer Res 2009, 15:1024-1031. 10.1158/1078-0432.CCR-08-1143, 2728013, 19188175.
10. Hazzaa SM, Elashry OM, Afifi IK. Clusterin as a diagnostic and prognostic marker for transitional cell carcinoma of the bladder. Pathol Oncol Res 2009, 16:101-109.
11. Zavada J, Zavadova Z, Zat'ovicova M, Hyrsl L, Kawaciuk I. Soluble form of carbonic anhydrase IX (CA IX) in the serum and urine of renal carcinoma patients. Br J Cancer 2003, 89:1067-1071. 10.1038/sj.bjc.6601264, 2376963, 12966427.
12. Vasudev NS, Sim S, Cairns DA, Ferguson RE, Craven RA, Stanley A, Cartledge J, Thompson D, Selby PJ, Banks RE. Pre-operative urinary cathepsin D is associated with survival in patients with renal cell carcinoma. Br J Cancer 2009, 101:1175-1182. 10.1038/sj.bjc.6605250, 2768081, 19789534.
13. Pories SE, Zurakowski D, Roy R, Lamb CC, Raza S, Exarhopoulos A, Scheib RG, Schumer S, Lenahan C, Borges V. Urinary metalloproteinases: noninvasive biomarkers for breast cancer risk assessment. Cancer Epidemiol Biomarkers Prev 2008, 17:1034-1042. 10.1158/1055-9965.EPI-07-0365, 18483323.
14. Yamaguchi T, Takahashi T, Yokota T, Kitamura K, Noguchi A, Kamiguchi M, Doi M, Ahn T, Sawai K, Yamane T. Urinary pepsinogen I as a tumor marker of stomach cancer after total gastrectomy. Cancer 1991, 68:906-909. 10.1002/1097-0142(19910815)68:4<906::AID-CNCR2820680438>3.0.CO;2-5, 1649690.
15. Dong LM, Shu XO, Gao YT, Milne G, Ji BT, Yang G, Li HL, Rothman N, Zheng W, Chow WH, Abnet CC. Urinary prostaglandin E2 metabolite and gastric cancer risk in the Shanghai women's health study. Cancer Epidemiol Biomarkers Prev 2009, 18:3075-3078. 10.1158/1055-9965.EPI-09-0680, 2783404, 19861525.
16. Tsigris C, Karayiannakis AJ, Syrigos KN, Zbar A, Diamantis T, Kalahanis N, Alexiou D. Clinical significance of soluble c-erbB-2 levels in the serum and urine of patients with gastric cancer. Anticancer Res 2002, 22:3061-3065.
17. Cui J, Chen Y, Chou WC, Sun L, Chen L, Suo J, Ni Z, Zhang M, Kong X, Hoffman LL. An integrated transcriptomic and computational analysis for biomarker identification in gastric cancer. Nucleic Acids Res 2010, 39:1197-1207. 3045610, 20965966.
18. Hong CS, Cui J, Ni Z, Su Y, Puett D, Li F, Xu Y. A computational method for prediction of excretory proteins and application to identification of gastric cancer markers in urine. PLoS One 2011, 6:e16875. 10.1371/journal.pone.0016875, 3041827, 21365014.
19. Hirata K, Dichek HL, Cioffi JA, Choi SY, Leeper NJ, Quintana L, Kronmal GS, Cooper AD, Quertermous T. Cloning of a unique lipase from endothelial cells extends the lipase gene family. J Biol Chem 1999, 274:14170-14175. 10.1074/jbc.274.20.14170, 10318835.
20. Jaye M, Lynch KJ, Krawiec J, Marchadier D, Maugeais C, Doan K, South V, Amin D, Perrone M, Rader DJ. A novel endothelial-derived lipase that modulates HDL metabolism. Nat Genet 1999, 21:424-428. 10.1038/7766, 10192396.
21. Rader DJ, Jaye M. Endothelial lipase: a new member of the triglyceride lipase gene family. Curr Opin Lipidol 2000, 11:141-147. 10.1097/00041433-200004000-00006, 10787175.
22. Annema W, Tietge UJ. Role of hepatic lipase and endothelial lipase in high-density lipoprotein-mediated reverse cholesterol transport. Curr Atheroscler Rep 2011, 13:257-265. 10.1007/s11883-011-0175-2, 3085744, 21424685.
23. Yasuda T, Ishida T, Rader DJ. Update on the role of endothelial lipase in high-density lipoprotein metabolism, reverse cholesterol transport, and atherosclerosis. Circ J 2010, 74:2263-2270. 10.1253/circj.CJ-10-0934, 20962428.
24. Huang J, Qian HY, Li ZZ, Zhang JM, Wang S, Tao Y, Gao YL, Yin CQ, Que B, Sun T. Role of endothelial lipase in atherosclerosis. Transl Res 2010, 156:1-6. 10.1016/j.trsl.2010.05.003, 20621031.
25. Wu X, Huang H, Tang F, Le K, Xu S, Liu P. Regulated expression of endothelial lipase in atherosclerosis. Mol Cell Endocrinol 2010, 315:233-238. 10.1016/j.mce.2009.11.003, 19931348.
26. Takasu S, Mutoh M, Takahashi M, Nakagama H. Lipoprotein lipase as a candidate target for cancer prevention/therapy. Biochem Res Int 2012, 2012:398697. 3199119, 22028972.
27. Lu J, Li J, Ji C, Yu W, Xu Z, Huang S. Expression of lipoprotein lipase associated with lung adenocarcinoma tissues. Mol Biol Rep 2008, 35:59-63. 10.1007/s11033-006-9053-3, 17347923.
28. Nielsen JE, Lindegaard ML, Friis-Hansen L, Almstrup K, Leffers H, Nielsen LB, Rajpert-De Meyts E. Lipoprotein lipase and endothelial lipase in human testis and in germ cell neoplasms. Int J Androl 2004, 33:e207-e215.
29. Haraldsson B, Sorensson J. Why do we not all have proteinuria? An update of our current understanding of the glomerular barrier. News Physiol Sci 2004, 19:7-10.
30. Griffon N, Jin W, Petty TJ, Millar J, Badellino KO, Saven JG, Marchadier DH, Kempner ES, Billheimer J, Glick JM, Rader DJ. Identification of the active form of endothelial lipase, a homodimer in a head-to-tail conformation. J Biol Chem 2009, 284:23322-23330. 10.1074/jbc.M109.037002, 2749106, 19567873.
31. Parks SK, Chiche J, Pouyssegur J. pH control mechanisms of tumor survival and growth. J Cell Physiol 2011, 226:299-308. 10.1002/jcp.22400, 20857482.
32. Demirag GG, Sullu Y, Gurgenyatagi D, Okumus NO, Yucel I. Expression of plakophilins (PKP1, PKP2, and PKP3) in gastric cancers. Diagn Pathol 2011, 6:1. 10.1186/1746-1596-6-1, 3025932, 21194493.
33. Lee J, Seo JW, Jun HJ, Ki CS, Park SH, Park YS, Lim HY, Choi MG, Bae JM, Sohn TS. Impact of MET amplification on gastric cancer: possible roles as a novel prognostic marker and a potential therapeutic target. Oncol Rep 2011, 25:1517-1524.
34. Zhao J, Zhang X, Xin Y. Up-regulated expression of Ezrin and c-Met proteins are related to the metastasis and prognosis of gastric carcinomas. Histol Histopathol 2011, 26:1111-1120.